Replies to post #316991 on Anavex Life Sciences Corp (AVXL)

[sokol]

Possibly Biogen will be more desperate now with the LLY competition? So, what moves may Biogen make? My understanding is that LLY’s drug is safer. LLY’s drug is not surrounded by the controversy that Biogen faces. Biogen may be forced to go the acquisition route?